Free oxygen radicals and surfactant

Neonatology

Volumn 71, Issue 1, 1997, Pages 23-27

  Bracci, Rodoifo ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; LUNG SURFACTANT; OXYGEN RADICAL;

ARTICLE; HUMAN; HUMAN TISSUE; LIPID PEROXIDATION; LUNG INJURY; NEWBORN; OXIDATIVE STRESS; PREMATURITY; PRIORITY JOURNAL;

ANTIOXIDANTS; FREE RADICALS; HUMANS; INFANT, NEWBORN; LIPID PEROXIDATION; OXIDATIVE STRESS; OXYGEN; PULMONARY SURFACTANTS;

EID: 0030949660     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000244449     Document Type: Article

References (35)

1. Frank L: Developmental aspects of experimental pulmonary oxygen toxicity, Free Radical Biol Med 1991;11:463-494.
2. Frank L: Oxygen toxicity and the protective antioxidant enzyme system of the lung, Biol Neonate 1996; 69:165-212.
3. Moison RMW, Palinckx JJS, Roest M, Houdkamp E, Berger HM: Induction of lipid peroxidation of pulmonary surfactant by plasma of preterm babies, lancet 1993;341:79- 82.
4. Pitkanen OM, Hallman M, Andcrs-son S: Correlation of free oxygen radical-induced lipid peroxidation with outcome in very low birth weight infants, J Pediatr 1990; 116: 760-764.
5. Saugstad OD: Mechanisms of tissue injury by oxygen radicals: Implications for neonatal disease, Acta Pae-diatr 1996;85:1-4.
6. Grigg J, Arnon S, Chase S, Silverman M: Inflammatory cells in the lungs of premature infants on the first day of life: perinatal risk factors and origin of cells, Arch Dis Child 1993;69:40-43.
7. Contreras M, Hariharan N, Iewan-doski JR, Ciesielski W, Koscik R, Zimmerman JJ: Bronchoalvcolar oxyradical inflammatory elements herald bronchopulmonary dysplasia, Crit Care Med 1996;24:29-37.
8. Brus F, van Ocvercn W, Okken A, Bantbang Oetomo S: Activation of circulating polymorphonuclear leukocytes in preterm infants with severe idiopathic respiratory distress syndrome, Pediatr Res 1996:39: 456-463.
9. Bracci R, Bencdctti PA, Ciambcllot-ti V: Hydrogen peroxide generation in the erythrocytes of newborn infants, Biol Neonate 1970; 15:135- 141.
10. Buonocore G, Zani S, Sargentini I, Bracci R: Inlraerythrocytc free iron levels and oxidative stress in the newborn, Pediatr Res 1995:37: 280
11. Van Golde LMG: Potential role of surfactant proteins A and D in innate lung defense against pathogens, Biol Neonate 1995;67(suppl 1):2- 17.
12. Stuait GR, Sim RB, Malhotra R: Characterization of radioiocinated lung surfactant protein A (SP-A) and the effects of oxidation on SP-A quaternary structure and activity, Exp Lung Res 1996;22:467-487.
13. Cifucntcs J, Ruiz-Oronoz J, Myles C, Nieves B, Carlo WA, Matalon S: Interaction of surfactant mixtures with reactive oxygen and nitrogen species, J Appl Physiol 1995:78: 1800-1805.
14. Hallman M, WafTarn F, Bry K, Tur-bow R, Klcinman MT, Mautz WJ, Rasmussen RE, Bhalla DK, Phalen RF: Surfactant dysfunction after inhalation of nitric oxide, J Appl Physiol 1996:80:2026-2034.
15. Bates SR, Fisher AB: Surfactant protein A is degraded by alveolar macrophages, Am J Physiol 1996:271: L258-L266.
16. Ryan SF, Ghassibi Y, Liau DF: Effects of activated polymorphonuclear leucocytes upon pulmonary surfactant in vitro, Am J Rcspir Cell Mol Biol 1991;4:33-41.
17. Kotccha S, Chan B, Azam N, Silverman M, Shaw RJ: Increase in inter-lcukin-8 and soluble intercellular adhesion molecule-1 in bronchoal-veolar lavage fluid from premature infants who develop chronic lung disease, Arch Dis Child 1995;72: F90-F96.
18. Murch SH, Costeloc K, Klein NJ, MacDonald TT: Early production of macrophage inflammatory protein-la occurs in respiratory distress syndrome and is associated with poor outcome, Pediatr Res 1996:40:490-497.
19. Liau DF, Yin NX, Huang J, Ryan SF: Effects of human polymorphonuclear leukocyte elastasc upon surfactant proteins in vitro, Biochim Biophys Acta 1996; 1302:117-128.
20. Schrod L, Hornemann F, von Stockhausen H-B: Chemi luminoscence activity of phagocytes from tracheal aspirates of premature infants after surfactant therapy, Acta Paediatr 1996;8:719-723.
21. Joncs CA, Cayabyab RG, Kwong KYC, Stotts C, Wong B, Harndan H, Minoo P, DeLemos RA: Undetectable interleukin (IL)-10 and persistent II,-8 expression early in hyaline membrane disease: A possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns, Pediatr Res 1996;39:966-975.
22. Kobayashi T, Nitta K, Ganzuka M, Inui S, Grossmann G, Robertson B: Inactivation of exogenous surfactant by pulmonary edema fluid, Pediatr Res 1991:29:353-356.
23. Toti P, Buonocorc G, Rinaldi G, Catella AM, Bracci R: Pulmonary pathology in surfactant-trcatcd preterm infants with respiratory distress syndrome: An autopsy study, Biol Neonate 1996;70:21-28.
24. Jackson RM, Brannen AL, Veal CF, Fulmer JD: Supcroxidc dismutasc and cytochrome oxidase in collapsed lungs: possible role in reexpansion edema, J Appl Physiol 1988:65:235-241.
25. Ahuja A, Oh N, Chao W, Spragg RG, Smith RM: Inhibition of the human neutrophil respiratory burst by native and synthetic surfactant, Am J RcspirCell Mol Biol 1996; 14: 496-503.
26. McIntosh JC, Mcrvin-Blakc S, Conner E, Wright JR: Surfactant protein A protects growing cells and reduces TNF-a activity from LPS-stimulat-cd macrophages, Am J Physiol 1996:271:L310-L319.
27. Hayakawah H, Giridhar G, Myr-vik QN, Kuccr L: Pulmonary surfactant phospholipids modulate priming of rabbit alveolar macrophages for oxidative responses, J Leukoc Biol 1992;51:379-385.
28. Van Iwaardcn JF, Shimizu H, van Golde PHM, Voelker DR, van Golde LMG: Rat surfactant protein D enhances the production of oxygen radicals by rat alveolar macrophages, Biochem J 1992;286:5-8.
29. Buonocorc G, Gioia D, De Filippo M, Picciolini E, Bracci R: Superoxide anion release by polymorphonuclear leukocytes in whole blood of newborns and mothers during the pcripartal period, Pcdiatr Res 1994; 36:619-622.
30. Roscnfcld WN, Evans H, Concepcion L, Jhaveri R, Schaeffer H, Friedman A: Prevention of bronchopulmonary dysplasia by administration of bovine supcroxidc dis-mutase in preterm infants with respiratory distress syndrome, J Pe-diatr 1984;105:781-784.
31. Tang G, White RJ, Gordon RJ, Lumb PD, Tsan MF: Polyelhylene glycol-conjugated superoxide dismutasc protects rats against oxygen toxicity, J Appl Physiol I993;74: 1425-1431.
32. Tanswell AK, Freeman BA: Liposome-entrapped antioxidant enzymes prevent lethal Oj toxicity in the newborn rat, J Appl Physiol 1987;63:347-352.
33. Sahgal N, Davis JM, Robbins C, Horowitz S, Langcnback EG, Perry RH, Coltlesh D, Tierney J, Simon SR: Localization and activity of recombinant human CuZn supcroxidc dismutase after intratracheal administration, Am J Physiol 1996; 27 L230-L235.
34. Walther FJ, David-Cu R, Lopez SL: Antioxidant-surfactant liposomes mitigate hyperoxic lung injury in premature rabbits, Am J Physiol 1995;269:L613-L617.
35. Rosenfcld WN, Davis JM, Parton L, Richter SE, Price A, Flaster E, Kas-sem N: Safety and pharmacokinetics of recombinant human supcroxide dismutase administered intratra-cheally to premature neonates with respiratory distress syndrome, Pediatrics 1996:97:811-817